
#How MIT's AI Is Designing Proteins and Slashing Drug Discovery Costs in 2026
How MIT’s BoltzGen and Boltz-2 AI models design proteins, predict binding affinity, and slash drug discovery costs.
Bi-weekly, we drop fresh prompts, new model insights, and hidden gems from the AI world so you can impress your team, sharpen your projects, and always know what’s next.
Get AI's latest in your inbox, once a week.